The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

We are investigating the mechanisms by which cancer mutations deregulate the normal processes of cellular function and growth ...

Numerous studies have suggested the cultivation of cells derived from intestinal organoids as two-dimensional (2D) monolayers ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Artios Pharma, a startup developing drugs that weaken a tumor’s ability to maintain its DNA, announced positive results in a ...

“This is a clear and deliberate shift,” Corbett says.

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...

New research from SAHMRI and Flinders University has shed light on how the decades-old antipsychotic drug, trifluoperazine ...

A world-first clinical trial launched in Melbourne is being hailed as a "game-changer" for its potential to revolutionize the ...